Who needs to carry an epinephrine autoinjector?

Area of Science:

• Allergy and Immunology
• Emergency Medicine

Background:

• Anaphylaxis is a severe allergic reaction requiring immediate treatment.
• Epinephrine autoinjectors are the first-line treatment for anaphylaxis.
• Certain patient populations may have unique considerations regarding epinephrine autoinjector use.

Purpose of the Study:

• To review the indications and contraindications for epinephrine autoinjector use.
• To highlight specific patient groups requiring individualized risk-benefit assessment for epinephrine autoinjector prescription.

Main Methods:

• Literature review on anaphylaxis management and epinephrine autoinjector guidelines.
• Analysis of patient factors influencing epinephrine autoinjector safety and efficacy.

Main Results:

• Epinephrine autoinjectors are recommended for all patients with a history of anaphylaxis or at high risk.
• Special populations, including those with atherosclerotic heart disease, elderly patients on polypharmacy, and those undergoing allergen immunotherapy, require careful evaluation.
• Individuals with oral allergy syndrome or large local reactions to insect stings also warrant individualized assessment.

Conclusions:

• The decision to prescribe an epinephrine autoinjector should be individualized.
• Healthcare providers must weigh the benefits of epinephrine autoinjector availability against potential risks in specific patient subsets.
• Patient education on proper autoinjector use and risk factors is essential for effective anaphylaxis management.